Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;87(2):447-448.
doi: 10.1016/j.jaad.2021.09.017. Epub 2021 Sep 16.

Comparative responsiveness of cutaneous lupus erythematosus patients to methotrexate and mycophenolate mofetil: A cohort study

Emily Keyes  1 , Anisha Jobanputra  1 , Rui Feng  2 , Madison Grinnell  1 , Thomas Vazquez  1 , DeAnna Diaz  1 , Victoria P Werth  3
Affiliations

Comparative responsiveness of cutaneous lupus erythematosus patients to methotrexate and mycophenolate mofetil: A cohort study

Emily Keyes et al. J Am Acad Dermatol. 2022 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest Authors Keyes, Jobanputra, Grinnell, Vazquez, and Diaz and Drs Feng and Werth do not have any conflicts of interest to disclose. The University of Pennsylvania owns the copyright for the CLASI.

References

    1. Kuhn A, Aberer E, Bata-Csörgő Z, et al. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2017;31(3):389–404 - PubMed
    1. Reich A, Werth VP, Furukawa F, et al. Treatment of cutaneous lupus erythematosus: current practice variations. Lupus. 2016;25(9):964–972. - PubMed
    1. Kreuter A, Tomi NS, Weiner SM, Huger M, Altmeyer P, Gambichler T. Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy. Br J Dermatol. 2007. Jun;156(6):1321–7. - PubMed
    1. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981;4(4):471–475.. - PubMed
    1. Chakka S, Krain RL, Ahmed S, Concha JSS, Feng R, Merrill JT, Werth VP. Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus. J Am Acad Dermatol. 2021. Jun;84(6):1562–1567. - PMC - PubMed

Publication types

MeSH terms